Person:
ELÇİOĞLU, ÖMER CELAL

Loading...
Profile Picture
Status
Organizational Units
Organizational Unit
Job Title
First Name
ÖMER CELAL
Last Name
ELÇİOĞLU
Name
Email Address
Birth Date

Search Results

Now showing 1 - 10 of 31
  • PublicationOpen Access
    Comparative Evaluation of Orthostatic Hypotension in Patients with Diabetic Nephropathy.
    (2021-07-20T00:00:00Z) Aytaş, Gamze; Elçioğlu, Ömer C; Kazancıoğlu, Rümeyza; Gürsu, Meltem; Artan, A Serra; Yabacı, Ayşegül; Soysal, PINAR; Bilgi, Kadir; Özçelik, Semra; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL; GÜRSU, MELTEM; YABACI TAK, AYŞEGÜL; SOYSAL, PINAR; ÖZÇELİK, SEMRA
    Introduction: Orthostatic hypotension (OH) affects 5-20% of the population. Our study investigates the presence of OH in diabetic nephropathy (DNP) patients and the factors affecting OH in comparison with nondiabetic chronic kidney disease (NDCKD) patients. Method: Patients presented to the nephrology clinic, and those who consented were included in the study. DNP was defined by kidney biopsy and/or clinical criteria. NDCKD patients of the same sex, age, and eGFR were matched to DNP patients. Demographic parameters and medications were obtained from the records. OH was determined by Mayo clinic criteria. The same researcher used an electronic device to measure blood pressure (BP). All samples were taken and analyzed the same day for biochemical and hematologic parameters and albuminuria. Results: 112 (51 F, 61 M, mean age: 62.56 ± 9.35 years) DNP and 94 (40 F, 54 M, mean age: 62.23 ± 10.08 years) NDCKD patients were included. There was no significant difference between DNP and NDCKD groups in terms of OH prevalence (70.5 vs. 61.7%, p = 0.181). Male patients had significantly higher OH prevalence than female patients (74.7 vs. 60.0%, p = 0.026). There was no significant difference in change in systolic BP between the groups (24.00 [10.00-32.00] mm Hg vs. 24.00 [13.75-30.25] mm Hg, p = 0.797), but the change in diastolic BP was significantly higher in the DNP group (8.00 [2.00-13.00] mm Hg vs. 6.00 [2.00-9.00] mm Hg, p = 0.025). In the DNP group, patients with OH had significantly higher uric acid levels than those without OH (7.18 ± 1.55 vs. 6.36 ± 1.65 mg/dL, p = 0.017). And, 73.7% of patients on calcium channel blockers developed OH (p = 0.015), and OH developed in 80.6% of 36 patients on alpha-blockers (p = 0.049). Conclusion: OH prevalence is very high in CKD, and etiology of CKD does not have a statistically significant effect on the frequency of OH, despite a difference that could be meaningful clinically. Therefore, patients with CKD are checked for OH, with or without concurrent diabetes mellitus. Evaluation of postural BP changes should be a part of nephrology practice.
  • PublicationMetadata only
    Assessment of Mean Platelet Volume in Patients with AA Amyloidosis and AA Amyloidosis Secondary to Familial Mediterranean Fever: A Retrospective Chart - Review Study
    (2019-05-24T00:00:00Z) BAKAN, Ali; Oral, Alihan; ECDER, Sabahat Alisir; KUZGUN, Gulsah Sasak; Elcioglu, Omer Celal; demirci, Recep; Bahat, Kubra Aydin; ODABAS, Ali Riza; ELÇİOĞLU, ÖMER CELAL
    Background: Amyloidosis is a protein-misfolding disease characterized by the deposition of aggregated proteins in the form of abnormal fibrils that disrupt tissue structure, ultimately causing disease. Amyloidosis is very frequent in untreated familial Mediterranean fever (FMF) patients and it is the most important feature that determines the prognosis of FMF disease. The mean platelet volume (MPV) in FMF has been previously studied. However, whether MPV level in FMF patients is lower or higher compared to healthy controls remains a topic of ongoing debate. In this study, we aimed to investigate MPV values and to assess the correlation between MPV and proteinuria in patients with AA amyloidosis and AA amyloidosis secondary to familial Mediterranean fever (AA-FMF) through a retrospective chart-review.
  • PublicationMetadata only
    Retrobulbar blood flow and carotid intima-media thickness alteration may relate to subclinic atherosclerosis in patients with chronic inflammatory diseases
    (2015-01-01T00:00:00Z) KELES, Nursen; CALISKAN, Mustafa; AKSU, Feyza Ulusoy; KELES, Necibe Nur; KARAGOZ, Vildan; TEKIN, Ahmet Selami; AKCAKOYUN, Mustafa; KOSTEK, Osman; Elcioglu, Omer; Aung, Soe Moe; BAKAN, Ali; ODABAS, Ali Riza; ELÇİOĞLU, ÖMER CELAL
    Objective: AA amyloidosis occurs in the setting of longstanding inflammation. An increased incidence of coronary artery disease (CAD) was noted in patients with chronic inflammatory disease (CID). Retrobulbar blood flow predicts future macrovascular events including CAD. Increase in carotid artery intima-media thickness is regarded as a marker for early atherosclerosis. The relationship between chronic inflammation and atherosclerosis is well known; however, the connection between amyloidosis-advanced CIDs and retrobulbar microvascular function and carotid intima-media thickness (CIMT) is unidentified. We aimed to investigate whether retrobulbar microcirculation and CIMT were impaired or not in amyloidosis-advanced CID patients compared to normal subjects. Methods: Fourteen patients with renal AA amyloidosis and a group of healthy volunteers were included in the study. Measurement of CIMT and retrobulbar blood flow velocities was performed with ultrasound scanner and color Doppler ultrasonography. Results: The CIMT of patients with renal amyloidosis was significantly thicker than that of the normal population (p<0.001). The resistivity index of the ophthalmic artery (OA) of patients with renal amyloidosis was significantly higher than the study group (p<0.001). Conclusion: This study demonstrates that accelerated atherosclerosis which can be shown by increased OA resistivity index and CIMT are found in amyloidal-related CID patients.
  • PublicationOpen Access
    COVİD-19 infection in a membranous nephropathy patient treated with rituximab.
    (2020-09-04T00:00:00Z) Elcioglu, Omer Celal; Artan, Ayse Serra; Mirioglu, Safak; Gursu, Meltem; Durdu, Bulent; Koc, Meliha Meric; Okyaltirik, Fatmanur; Gultekin, Mehmet Ali; Kazancioglu, Rümeyza; ELÇİOĞLU, ÖMER CELAL; MİRİOĞLU, ŞAFAK; GÜRSU, MELTEM; DURDU, BÜLENT; MERİÇ KOÇ, MELİHA; OKYALTIRIK, FATMANUR; GÜLTEKİN, MEHMET ALİ; KAZANCIOĞLU, RÜMEYZA
    While COVID-19 pandemic continues to afect our country and most countries in the world, we have to make some changes both in our social life and our approach to healthcare. We have to struggle with the pandemic on one hand and also try to follow up and treat our patients with chronic diseases in the most appropriate way. In this period, one of our group of patients who are challenging us for follow-up and treatment are those who should start or continue to use immunosuppressive therapy. In order to contribute to the accumulation of knowledge in this area, we wanted to report a patient who was followed up with the diagnosis of COVID-19 and had been administered rituximab very recently due to a nephrotic syndrome caused by membranous nephropathy.
  • PublicationMetadata only
    FAMİLYAL HİPOKALSÜRİK HİPERKALSEMİ
    (Güneş Kitabevi, 2022-11-01) Elçioğlu Ö. C.; ELÇİOĞLU, ÖMER CELAL
  • PublicationMetadata only
    Vasculitis in a patient with hairy cell leukemia.
    (2011-01-01T00:00:00Z) OZKOK, A; Elcioglu, OC; AKPINAR, TS; NALCACI, M; ELÇİOĞLU, ÖMER CELAL
  • PublicationMetadata only
    Nadir Bir Kateter İlişkili Enfeksiyon Etkeni; Achromobacter Denitrificans
    (2022-11-09) Çıngar Alpay K.; Gürsu M.; Elçioğlu Ö. C.; Mirioğlu Ş.; Kazancıoğlu R.; ÇINGAR, KÜBRA; GÜRSU, MELTEM; ELÇİOĞLU, ÖMER CELAL; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZA
  • PublicationMetadata only
    Covid-19 Pandemisinin Peritonit Hızı Üzerine Etkisi
    (2022-11-09) Gürsu M.; Mirioğlu Ş.; Köse E.; Yücel L.; Sayan C.; Elçioğlu Ö. C.; Kazancıoğlu R.; GÜRSU, MELTEM; MİRİOĞLU, ŞAFAK; ELÇİOĞLU, ÖMER CELAL; KAZANCIOĞLU, RÜMEYZA
  • PublicationMetadata only
    Propylthiouracil-induced Cryoglobulinemic Vasculitis
    (2013-01-01T00:00:00Z) ODABAŞ, ALİ RIZA; Kaya, Suheyla; ELÇİOĞLU, Ömer Celal; ELÇİOĞLU, ÖMER CELAL
  • PublicationMetadata only
    Reversible Posterior Leukoencephalopathy in the Course of Goodpasture Syndrome
    (2012-01-01T00:00:00Z) OZKOK, Abdullah; Elcioglu, Omer Celal; BAKAN, Ali; ATILGAN, Kadir Gokhan; ALISIR, Sabahat; ODABAS, Ali Riza; ELÇİOĞLU, ÖMER CELAL
    Reversible posterior leukoencephalopathy syndrome (RPLS) is characterized by headache, altered consciousness, seizures, and cortical blindness. The most frequent etiological factors are hypertension, kidney diseases, and immunosuppressive drugs such as steroids and cyclophosphamide. Herein we present a case of a 22-year-old female patient presented with alveolar hemorrhage and acute renal failure necessitating hemodialysis. In renal biopsy, necrotizing crescentic glomerulonephritis and immunofluorescence pattern compatible with Goodpasture syndrome were found. Anti-glomerular basement membrane antibody result was positive. At follow-up, respiratory failure ensued, steroid pulse treatment was started, and she was transferred to intensive care unit (ICU). In the ICU, she had visual disturbances and blindness together with seizures. Cranial magnetic resonance imaging (MRI) revealed irregular T2- and fluid-attenuated inversion recovery (FLAIR)-weighted lesions in bilateral occipital lobes. On clinical and radiological grounds, RPLS was diagnosed. With the supportive and anti-hypertensive treatment, RPLS was resolved without a sequela. Subsequent cranial MRI was totally normal. In the literature, RPLS associated with Goodpasture syndrome was reported only once. Hypertension and methylprednisolone might be the responsible etiologies in this case.